Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1994-11-14
2000-09-05
Duffy, Patricia A.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 71, 435 792, 436518, 436811, G01N 3353
Patent
active
06114133&
ABSTRACT:
This invention provides methods useful in aiding in the diagnosis of Alzheimer's disease. The methods involve measuring the amount of amyloid-.beta. peptide (x-.gtoreq.41) in the cerebrospinal fluid of a patient. High levels of the peptide generally are inconsistent with a diagnosis of Alzheimer's. Low levels of the peptide are consistent with the disease and, with other tests, can provide a positive diagnosis.
REFERENCES:
patent: 4474892 (1984-10-01), Murad et al.
patent: 4666829 (1987-05-01), Glenner et al.
patent: 5213962 (1993-05-01), Van Nostrand et al.
patent: 5220013 (1993-06-01), Ponte et al.
patent: 5223482 (1993-06-01), Schilling, Jr., et al.
patent: 5234814 (1993-08-01), Card et al.
patent: 5262332 (1993-11-01), Selkoe
patent: 5750349 (1998-05-01), Suzuki et al.
Vigo-Pelfry et al, J. Neurochemistry, 61:1965-1968, 1993.
N. Suzuki et al. (1994) Science 264:1336-1340. An increased Percentage of Long Amyloid .beta. Protein Secreted by Familial Amyloid .beta. Protein Precursor (.beta.APP.sub.717) Mutants.
van Gool and Bolhuis, "Cerebrospinal Fluid Markers of Alzheimer's Disease", JAGS, 39:1025-1039 (1991).
Haass et al. (1992) Nature 359:322-325. Amyloid .beta.-peptide is produced by cultured cells during normal metabolism.
Wolozin et al. (1987) Annals of Neurology 22(4):521-526. Alzheimer-Related Neuronal Protein A68: Specificity and Distribution.
Ueda et al. (1990) The Journal of Neuroscience 10(10):3295-3304. Alz-50 Recognizes a Phosphorylated Epitope of Tau Protein.
Chui et al. (1993) Arch Neurol 50:57-63. Reliability and Usefulness of a New Immunochemical Assay for Alzheimer's Disease.
H. Hamazaki (1995) Biochem. Biophys. Res. Comm. 211(2):349-353. Amyloid P Component Promotes Aggregation Of Alzheimer's .beta.-Amyloid Peptide.
R. Motter et al. (1995) Annals of Neurology 38(4):643-648 Reduction of .beta.-Amyloid Peptide.sub.42 in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
L. Chang et al. (1994) Neurology v 44 (4 Sup. 2) .beta.-Amyloid Protein in Cerebrospinal Fluid of Alzheimer Disease: Correlations with MMSE.
L. Higgins et al. (1994) Annals of Neurology 35(5):598-607 Transgenic Mouse Brain Histopathy Resembles Early Alzheimer's Disease.
G. Murphy (1994) American J. of Pathology 144(5):1082-1088 Development of a Monoclonal Antibody Specific for the COOH-Terminal of .beta.-Amyloid 1-42 and Its Immunohistochemical Reactivity in Alzheimer's Disease and Related Disorders.
T. Pirttila (1994) J. Neurological Sciences 127:90-95. Soluble amyloid .beta.-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular demential and controls.
W. Van Nostrand et al. (1992) Proc. Natl. Acad. Sci USA 89:2551-2555 Decreased levels of soluble amyloid .beta.-protein precursor in cerebrospinal fluid of live Alzheimer's disease patients.
M. Tabaton et al. (1994) Biochem. Biophys. Res. Comm. 200(3):1598-1603 Soluble Amyloid .beta.-Protein Is A Marker Of Alzheimer Amyloid In Brain But Not In Cerebrospinal Fluid.
C. Vigo-Pelfrey et al. (1994) Society for Neuroscience Abstracts vol. 20 #191.2 Detection of A.beta..sub.1-42 In CSF And Various Cell Conditioned Media.
K. Urakami et al. (1992) Acta Neurol Scand 85:343-346. Amyloid .beta.protein precursors with kunitz-type inhibitor domains and acetyl-cholinesterase in cerebrospinal fluid from patients with demential of the Alzheimer type.
R. Prior et al. (1991) Neuroscience Letters 124:69-73. Quantitative changes in the amyloid .beta.A4 precursor protein in Alzheimer cerebrospinal fluid.
B. McDonald et al. (1988) Alzheimer Disease and Associated Disorders 2(3):186. The Characterisation And Purification Of A Protein Present In Cerebrospinal Fluid And Serum, Using A Monoclonal Antibody Which Reacts Immunohistochemically With Amyloid Deposits In Alzheimer Brains.
D. Allsop (1986) Neuroscience Letters 68:252-256. Monoclonal Antibodies Raised Against A Subsequence Of Senile Plaque Core Protein React With Plaque Cores. Plaque Periphery And Cerebrovascular Amyloid In Alzheimer's Disease.
T. Ishii (1986) Neuropathology and Applied Neurobiology 12:441-445. A Monoclonal Antibody To Amyloid In The Brains Of Patients With Alzheimer's Disease.
Glenner and Wong (1984) Biochem. Biophys. Res. Commun. 120:885-890.
Kang et al. (1987) Nature 325:733-736.
Roher et al. (1993) Proc. Natl. Acad. Sci. USA 90:1086-840.
Iwatsubo et al. (1994) Neuron 13:45-53.
Selkoe (1994) J. Neuropath. and Exp. Neurol. 53:438-447.
Selkoe (1991) Neuron 6:487.
Goate et al. (1991) Nature 349:704-706.
Chartier Harlan et al. (1991) Nature 353:844-846.
Murrell et al. (1991) Science 254:97-99.
Suzuki et al. (1994) Science 264:1336-1340.
Mullan et al. (1992) Nature Genet 1:345-347.
Glenner and Wong (1984) Biochem. Biophys. Res. Commun. 122:1131-1135.
Masters et al. (1985) Proc. Natl. Acad. Sci. USA 82:4245-4249.
Selkoe et al. (1986) J. Neurochem. 46:1820-1834.
Joachim et al. (1988) Brain Research 474:100-111.
Hilbich et al. (1991) J. Mol. Biol. 218:149-163.
Barrow and Zagorski (1991) Science 253:179-182.
Burdick et al. (1992) J. Biol. Chem. 267:546-554.
Palmert et al. (1989) Proc. Natl. Acad. Sci. USA 86:6338-6342.
Weidemann et al. (1989) Cell 57:115-126.
Henriksson et al. (1991) J. Neurochem. 56:1037-1042.
Palmert et al. (1990) Neurology 40:1028-1034.
Seubert et al. (1993) Nature 361:260-263.
Podlisny et al. (1990) Biochem. Biophys. Res. Commun. 167:1094-1101.
Rumble et al. (1989) N. Engl. J. Med. 320:1446-1452.
Schlossmacher et al. (1992) Neurobiol. Aging 13:421-434.
Wong et al. (1984) Proc. Natl. Acad. Sci USA 82:8729-8732.
Selkoe (1986) Neurobiol. Aging 7:425-432.
Pardridge et al. (1987) Biochem. Biophys. Res. Commun. 145:241-248.
Joachim et al. (1989) Nature 341:226-230.
Selkoe et al. (1989) Neurobiol. Aging 10:387-395.
Wisniewski, Alzheimer's disease, eds. Becker and Giocobini, Taylor and Francas, N.Y. p. 206, 1990.
Kim and Wisniewski, Techniques in Diagnostic Pathology, eds, Bullock et al., Academic Press, Boston p. 106.
Seubert et al. (1992) Nature 359:325-327.
Vigo-Pelfrey et al. (1993) J. Neurochem. 61:1965-1968.
Esch et al. (1990) Science 248:1122.
Anderson et al. (1991) Neuro Science Lett. 128:126-128.
Ponte et al. (1988) Nature 331:525-527.
Tanzi et al. (1988) Nature 331:528-530.
Kitaguchi et al. (1988) Nature 331:530-532.
Hardy (1992) Nature Genet. 1:233-234.
Barbour Robin
Schenk Dale B.
Seubert Peter A.
Vigo-Pelfrey Carmen
Duffy Patricia A.
Duvall Jean M.
Elan Pharmaceuticals Inc.
Eli Lilly & Company
Stratford Carol A.
LandOfFree
Methods for aiding in the diagnosis of Alzheimer's disease by me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for aiding in the diagnosis of Alzheimer's disease by me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for aiding in the diagnosis of Alzheimer's disease by me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2211003